Background. If no complete remission on chemotherapy is reached in head and neck rhabdomyosarcoma (RMS) in children, adjuvant radiotherapy and/or surgery are indicated. This often causes severe mutilation, and the prognosis is poor. Ablative surgery, moulage technique with afterloading brachytherapy
Amore protocol in pediatric head and neck rhabdomyosarcoma: Descriptive analysis of failure patterns
✍ Scribed by Joeri Buwalda; Nicole J. Freling; Leo E. C. M. Blank; Alfons J. M. Balm; Johannes Bras; Paul A. Voûte; Huib N. Caron; Paul F. Schouwenburg; Johannes H. M. Merks
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 93 KB
- Volume
- 27
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background.
The AMORE protocol is a local treatment for patients with nonorbital pediatric head and neck rhabdomyosarcoma (HNRMS). The objectives of this study were: (1) to assess the adequacy of the concept, and (2) to identify factors associated with relapse.
Methods.
We performed a retrospective multidisciplinary review of 22 children primarily treated according to the AMORE protocol, excluding two children with inadequate imaging data.
Results.
Seven patients had a local relapse, six within and one outside the residual tumor area. Five of the six patients with relapse in the residual area had gross total or debulking (incomplete) surgery, suboptimal position of the mold for brachytherapy, or both. In the 15 nonrecurrent cases, four patients had either incomplete surgery or suboptimal mold position. Both surgical and brachytherapeutic factors seem to be associated with relapse.
Conclusions.
AMORE is an adequate concept. More rigid preoperative imaging and intraoperative verification of the brachytherapy mold position might lead to a reduction in the number of local failures. © 2005 Wiley Periodicals, Inc. Head Neck 27: XXX–XXX, 2005
📜 SIMILAR VOLUMES
## Abstract ## Background. Our aim was to correlate patterns of failure with target volume delineations in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity‐modulated radiation therapy (IMRT) and to report subjective xerostomia outcomes after IMRT as compared with